Need Help? Call 1­-866-­796-­7386
« back to stock screener

  AKBA stock: Akebia Therapeutics Inc

Current Rating
Sell

Previous Rating

Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$2.85
Market Cap
519.6M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
1.95
P/S
1.64
Dividend %
-
P/CF
5.8
P/FCF
-
Op. Cash Flow
-110.4K
FCF
-
Op. Margin
-127.50%
Net Margin
-129.90%
ROE
-115.10%
ROI
-109.40%
ROA
-53.80%
EPS Growth
-17.50%
Current Ratio
2.0
Debt/Equity
38.90%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
ImmuCell Corporation (ICCC) $8.50 - - 69.5M Strong Buy
Amneal Pharmaceuticals Inc (AMRX) $5.68 - - 2.02B Strong Buy
Bristol-Myers Squibb Co (BMY) $65.60 - 3.10% 141.03B Strong Buy
AEterna Zentaris Inc. (USA) (AEZS) $0.91 - - 133.3M Strong Buy
Harvard Bioscience, Inc. (HBIO) $6.83 - - 217.4M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More